Have you received funds through HRSA's Provider Relief Fund? News you can use:
The Provider Relief Fund reporting portal will close for Reporting Period 2 on Thursday, March 31. Providers who received one or more payments exceeding $10,000 in the aggregate, during the second 'Payment Received Period' must report on their use of funds no later than that date.Provider Relief Fund Deadline Approaching
Mar 10, 2022 7:00:00 AM / by Leslie D McDowell, DNP, ANP-BC, RN
Fireside Chat: Medicaid Managed Care Hot Topics Thursday March 17, 5:30 - 6:30 PM
Mar 9, 2022 6:00:00 PM / by Leslie D McDowell, DNP, ANP-BC, RN posted in Medicaid Managed Care
Please join NC Medicaid Chief Medical Officer Dr. Shannon Dowler, Chief Quality Officer Kelly Crosbie, Maternal Health Medical Director Dr. Velma Taormina and Deputy Director of Member Operations Carolyn McClanahan for the March Fireside Chat on Thursday, March 17 from 5:30-6:30 p.m.
Read More
FDA Issues Alerts for Three COVID Antigen Tests
Mar 9, 2022 3:45:00 PM / by Leslie D McDowell, DNP, ANP-BC, RN posted in COVID-19, antigen test
On March 1, 2022, The Food and Drug Administration alerted health care providers and the public to three COVID-19 antigen tests that are not authorized or approved for distribution or use in the United States. Due to the potential for false results, FDA said providers should consider retesting patients with an authorized test if these tests were performed less than two weeks ago and they suspect an inaccurate result. (Source: American Hospital Association )
New ICD-10 Codes to Document COVID-19 Vaccination Status
Mar 9, 2022 9:30:00 AM / by Leslie D McDowell, DNP, ANP-BC, RN posted in COVID-19, Vaccination, ICD-10
In response to the ongoing COVID-19 public health emergency, the Centers for Disease Control and Prevention’s (CDC) National Center for Health Statistics (NCHS) is implementing three new diagnosis codes into the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) for reporting COVID-19 vaccination status, effective April 1, 2022.
2022 MIPS Promoting Interoperability Webinar
Mar 3, 2022 8:30:00 AM / by Practice Support Team posted in MIPS, Promoting Interoperability
Save the date for a webinar brought to you by our colleagues at Mountain Area Health Education Center
NC Medicaid PHP Healthy Blue adds 'Known Issues' bulletin to website
Mar 2, 2022 4:08:26 PM / by Leslie D McDowell, DNP, ANP-BC, RN posted in Medicaid Managed Care
Healthy Blue, an NC Medicaid Pre-Paid Health Plan, has updated its Healthy Blue Provider page to include a 'Known Issues Bulletin' of issues the PHP is working to resolve.
Earn CME in 15 minutes!
Mar 2, 2022 12:00:00 PM / by Leslie D McDowell, DNP, ANP-BC, RN posted in CME, healthy NC 2030, clinical corner
Each of the 15-minute activities uses the Results-Based Accountability framework of 'Turn the Curve' thinking, and can be taken at your own pace from a computer, tablet or smartphone.
It's Easy and Free to Connect with NCCARE360
Mar 2, 2022 8:30:00 AM / by Leslie D McDowell, DNP, ANP-BC, RN posted in Primary Care, nccare360, Pediatrics, care management, referral
If you are not already connected and using the NCCARE360 platform, now is the time to learn more! Join Meghan Knight, Community Engagement Manager for a free information session to learn how you can easily connect your patients to community resources.
Lifeline: A Program to help your low-income patients access services like Telehealth
Feb 24, 2022 8:00:00 AM / by Practice Support Team posted in telehealth, access, financial assistance
Lifeline is a federal government program that offers a monthly discount on phone, internet or bundled package bills to qualified low-income people, which can give them the tools to access services like telehealth. People living on Tribal Lands can receive additional benefit.
New monoclonal antibody therapy receives EUA for treatment of COVID-19
Feb 23, 2022 2:30:00 PM / by Practice Support Team posted in COVID-19, monoclonal antibodies
On February 11, 2022, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for a new monoclonal antibody for the treatment of COVID-19 that retains activity against the omicron variant.
